Birth outcomes in women who have taken leflunomide during pregnancy
Arthritis & Rheumatism2010Vol. 62(5), pp. 1494–1503
Citations Over TimeTop 1% of 2010 papers
Christina Chambers, Diana L. Johnson, Luther K. Robinson, Stephen R. Braddock, Ronghui Xu, Janina Lopez-Jimenez, Nicole Mirrasoul, Elizabeth Salas, Yunjun Luo, Shelia Jin, Kenneth Lyons Jones
Abstract
Although the sample size is small, these data do not support the notion that there is a substantial increased risk of adverse pregnancy outcomes due to leflunomide exposure among women who undergo cholestyramine elimination procedure early in pregnancy. These findings can provide some reassurance to women who inadvertently become pregnant while taking leflunomide and undergo the washout procedure.
Related Papers
- Clinical observation of Leflunomide combined with Methotrexate in treatment of rheumatoid arthritis(2011)
- Small dose of leflunomide for rheumatoid arthritis(2011)
- Clinical Efficacy of Leflunomide for Rheumatoid Arthritis(2010)
- Clinical study of leflunomide in the treatment of patients with active rheumatoid arthritis(2001)
- → Leflunomide combined with methotrexate in treatment of Rheumatoid Arthritis(2014)